Literature DB >> 17855815

The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock.

Emanuel P Rivers1, James A Kruse, Gordon Jacobsen, Kant Shah, Manisha Loomba, Ronny Otero, Ed W Childs.   

Abstract

BACKGROUND: Despite abundant experimental studies of biomarker patterns in early severe sepsis and septic shock, human data are few. Further, the impact of the severity of global tissue hypoxia resulting from resuscitative strategies on these early biomarker patterns remains unknown.
METHODS: The temporal patterns of interleukin-1 receptor antagonist, intercellular adhesion molecule-1, tumor necrosis factor-alpha, caspase-3, and interleukin-8 were serially examined over the first 72 hrs of hospitalization after early hemodynamic optimization strategies of early goal-directed vs. standard therapy for severe sepsis and septic shock patients. The relationship of these biomarker patterns to each hemodynamic optimization strategy, severity of global tissue hypoxia (reflected by lactate and central venous oxygen saturation), organ dysfunction, and mortality were examined.
RESULTS: Abnormal biomarker levels were present upon hospital presentation and modulated to distinct patterns within 3 hrs based on the hemodynamic optimization strategy. The temporal expression of these patterns over 72 hrs was significantly associated with the severity of global tissue hypoxia, organ dysfunction, and mortality.
CONCLUSION: In early severe sepsis and septic shock, within the first 3 hrs of hospital presentation, distinct biomarker patterns emerge in response to hemodynamic optimization strategies. A significant association exists between temporal biomarker patterns in the first 72 hrs, severity of global tissue hypoxia, organ dysfunction, and mortality. These findings identify global tissue hypoxia as an important contributor to the early inflammatory response and support the role of hemodynamic optimization in supplementing other established therapies during this diagnostic and therapeutic "window of opportunity."

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855815     DOI: 10.1097/01.ccm.0000281637.08984.6e

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  58 in total

1.  Counterpoint: should lactate clearance be substituted for central venous oxygen saturation as goals of early severe sepsis and septic shock therapy? No.

Authors:  Emanuel P Rivers; Ronald Elkin; Chad M Cannon
Journal:  Chest       Date:  2011-12       Impact factor: 9.410

2.  [Door-to-Action-Time].

Authors:  Wilfred Druml; Michael Hiesmayr
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

3.  Back to basics in septic shock.

Authors:  Mark J Peters; Joe Brierley
Journal:  Intensive Care Med       Date:  2008-03-28       Impact factor: 17.440

Review 4.  The evolution of an inflammatory response.

Authors:  Stephen F Lowry
Journal:  Surg Infect (Larchmt)       Date:  2009-10       Impact factor: 2.150

5.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 6.  Reducing the burden of acute respiratory distress syndrome: the case for early intervention and the potential role of the emergency department.

Authors:  Brian M Fuller; Nicholas M Mohr; Richard S Hotchkiss; Marin H Kollef
Journal:  Shock       Date:  2014-05       Impact factor: 3.454

7.  Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.

Authors:  Andrea Morelli; Christian Ertmer; Sebastian Rehberg; Matthias Lange; Alessandra Orecchioni; Valeria Cecchini; Alessandra Bachetoni; Mariadomenica D'Alessandro; Hugo Van Aken; Paolo Pietropaoli; Martin Westphal
Journal:  Crit Care       Date:  2009-08-10       Impact factor: 9.097

8.  Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock.

Authors:  H Bryant Nguyen; Manisha Loomba; James J Yang; Gordon Jacobsen; Kant Shah; Ronny M Otero; Arturo Suarez; Hemal Parekh; Anja Jaehne; Emanuel P Rivers
Journal:  J Inflamm (Lond)       Date:  2010-01-28       Impact factor: 4.981

Review 9.  Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges.

Authors:  Robert S Parker; Gilles Clermont
Journal:  J R Soc Interface       Date:  2010-02-10       Impact factor: 4.118

10.  Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial.

Authors:  Andrea Morelli; Christian Ertmer; Sebastian Rehberg; Matthias Lange; Alessandra Orecchioni; Amalia Laderchi; Alessandra Bachetoni; Mariadomenica D'Alessandro; Hugo Van Aken; Paolo Pietropaoli; Martin Westphal
Journal:  Crit Care       Date:  2008-11-18       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.